Baidu-backed Subtle Medical produces AI-driven medical imaging software intended to work across different healthcare systems, and has raised $12.2m.

Takeda Ventures and Astellas Venture Management both backed cell therapy developer Catamaran as it emerged from stealth.

George Washington and Minnesota universities-founded cell therapy developer Catamaran has raised cash to move two assets toward the clinic.

GV is among the investors in the pharmaceutical manufacturing technology startup, which recently secured $750m in series B funding.

The pharmaceutical firm will pay $425m up-front for University of Michigan and Ohio State University-founded OncoImmune after the latter pivoted its research pipeline to target severe cases of covid-19.

The Comcast and Anthem-backed telemedicine app developer closed its second round of the year, at a reported $700m valuation.

The Alphabet investment vehicle has helped the online therapist network close a series A round that increased its total funding to $32m.

Northwestern Mutual Future Ventures has reserved $20m for strategic investments in startups with black founders and formed a dedicated accelerator.

The WuXi AppTec, Celgene, Taikang and Tigermed-backed cancer drug developer went public in Hong Kong at the top of its range.

Strategic partner PPD returned for a round that helped the clinical trial software provider take its total funding past the $130m mark.